Test Price
1,600 AED✅ Home Collection Available
HER-2/neu (Breast Cancer) FISH Analysis in Dubai | 1600 AED | DHA Licensed
Executive Summary & Core Metrics
Clinical-Grade HER-2/neu FISH Analysis for Precise Breast Cancer Management
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
- Specimen Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval – hospital extraction only; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Complimentary telephonic post-test result interpretation by Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology (DHA: 61713011).
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
HER-2/neu (Human Epidermal Growth Factor Receptor 2) FISH testing on breast tumour tissue definitively determines gene amplification status, an essential step for selecting targeted therapies like trastuzumab (Herceptin) in invasive breast carcinoma. Our UAE-based laboratory uses high-sensitivity Fluorescence In-Situ Hybridization to directly visualize HER2 gene copy numbers, resolving any equivocal immunohistochemistry (IHC) results with unmatched precision.
| Feature | Our HER-2/neu FISH Test | Closest Alternative (IHC 2+ Reflex) |
|---|---|---|
| Precision | Direct gene amplification (copy number) – definitive positive/negative | Semi‑quantitative protein expression – equivocal results possible |
| Methodology | FISH (Fluorescence In-Situ Hybridization) with dual-colour probes | IHC with reflex FISH only when borderline |
| Turnaround Time | 7–8 working days | 5–14 days (variable, lab dependent) |
Physician Insight & Safety Protocols
"A precise HER2 FISH result guides tailored therapy decisions in breast cancer. However, it must be interpreted alongside histopathology, clinical history, and imaging findings. Do not base treatment changes on this test alone."
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011Medication Advisory
Do not discontinue prescribed medication without consulting your doctor.
Your current cancer treatment, including biologic agents, may influence test accuracy if not managed appropriately. Always inform your oncologist about all medications and supplements.
Safety Exclusion Criteria & Emergency Red Flags
Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Inadequate or non‑representative tumour sample (a core biopsy or surgical specimen is mandatory).
- Prior neoadjuvant chemotherapy/anti‑HER2 therapy within 3 weeks may alter HER2 status; consult your oncologist for optimal repeat testing timing.
- If you experience sudden worsening pain, shortness of breath, or neurological symptoms (e.g., confusion, weakness), seek emergency care immediately — do not wait for test results.
Patient FAQ & Clinical Guidance
1. What does a HER-2/neu FISH positive result mean for my breast cancer treatment?
A positive FISH result indicates HER2 gene amplification, making your tumour eligible for targeted anti‑HER2 therapies such as trastuzumab, pertuzumab, or antibody‑drug conjugates, which significantly improve survival outcomes. Always discuss the result with your oncologist to determine the best treatment plan.
2. Do I need a doctor’s prescription for this test in the UAE?
Yes, a doctor’s prescription is typically required; however, exceptions apply for patients planning to travel abroad, undergoing surgery, or in pregnancy cases where a prescription may not be mandated. We recommend consulting our clinical team via WhatsApp at +971 54 548 8731 for guidance.
3. How is the tumour sample collected and transported for HER-2/neu testing?
A formalin‑fixed paraffin‑embedded (FFPE) tumour tissue block or 4‑micron unstained slides are required. Our logistics team provides secure medical courier solid tissue specimen retrieval, ensuring cold‑chain (2‑8°C) transport from the hospital directly to our laboratory.
UAE Regulatory & Data Privacy Adherence
Compliance with Federal & Local Regulations
- Laboratory licensed by Dubai Health Authority (Facility License # 1143).
- Compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Patient consent and clinical safety adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ISO 9001:2015 Certified – Quality Management System (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | HER-2/neu (Breast Cancer) FISH Analysis |
| Price (AED) | 1,600 |
| Turnaround Time | 7–8 working days |
| Sample Type / Matrix | Formalin-fixed paraffin-embedded (FFPE) tumour tissue block or 4-micron unstained slides (Archival Tissue Specimen) |
| Methodology Used | Fluorescence In-Situ Hybridization (FISH) with dual-colour probes |
| ICD-10-CM Code | Z15.01, C50.9, Z85.3 |
| LOINC Code | 49663-4 |
| DHA Facility License & Laboratory Address | License # 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians